Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00553358
What this trial is testing

Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 455
Testing effectiveness (Phase 2)Study completedNCT02648477
What this trial is testing

Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more
City of Hope Medical Center 30
Not applicableStudy completedNCT04544475
What this trial is testing

A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause

Who this might be right for
Genitourinary Syndrome of Menopause (GSM)
NYU Langone Health 49
Post-approval studies (Phase 4)Study completedNCT03921736
What this trial is testing

Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

Who this might be right for
HypertensionHyperuricemiaMenopause
Anna Posadzy-Małaczyńska 180
Not applicableEnded earlyNCT00249847
What this trial is testing

Study of PET Scans and Serotonin in Hot Flashes Treatment

Who this might be right for
Hot Flashes
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Testing effectiveness (Phase 2)Ended earlyNCT01662726
What this trial is testing

Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth

Who this might be right for
Breast Neoplasms
Imperial College London 13
Large-scale testing (Phase 3)Study completedNCT00131495
What this trial is testing

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

Who this might be right for
Hypoactive Sexual Desire Disorder
Warner Chilcott 814
Large-scale testing (Phase 3)Study completedNCT00196378
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrophy

Who this might be right for
Menopause
Duramed Research 300
Post-approval studies (Phase 4)Study completedNCT00335218
What this trial is testing

Fat Distribution in Healthy Early Postmenopausal Women

Who this might be right for
HealthyPostmenopause
Bayer 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT03359954
What this trial is testing

Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeInvasive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT06067503
What this trial is testing

Biomarkers to Detect Endocrine Therapy Resistance

Who this might be right for
Metastatic CancerBreast CancerLobular Breast Carcinoma
University of Wisconsin, Madison 8
Testing effectiveness (Phase 2)Study completedNCT02632045
What this trial is testing

Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast Carcinoma
Melissa K Accordino 169
Large-scale testing (Phase 3)Active Not RecruitingNCT03725059
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

Who this might be right for
Breast Cancer
Merck Sharp & Dohme LLC 1,240
Not applicableStudy completedNCT04276272
What this trial is testing

D4 Choline Breast PET/CT

Who this might be right for
HER2-negative Breast CancerER Positive Breast CancerMetastatic Breast Cancer
Imperial College London 6
Large-scale testing (Phase 3)Ended earlyNCT00925548
What this trial is testing

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

Who this might be right for
Breast Cancer
EMD Serono 16
Not applicableStudy completedNCT01482416
What this trial is testing

Vascular Effect of Estrogens Versus Placebo Evaluated by Flow-mediated Dilatation of Brachial Artery

Who this might be right for
Unspecified Injury of Brachial Artery, Left Side, Initial Encounter
Federal University of Minas Gerais 60
Testing effectiveness (Phase 2)Study completedNCT04072952
What this trial is testing

A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Arvinas Estrogen Receptor, Inc. 217
Early research (Phase 1)Study completedNCT01840488
What this trial is testing

BN83495 Phase I in Post-menopausal Women

Who this might be right for
Breast Cancer
Ipsen 50
Testing effectiveness (Phase 2)Study completedNCT00001890
What this trial is testing

Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections

Who this might be right for
AtherosclerosisChlamydia InfectionsCytomegalovirus Infections+2 more
National Heart, Lung, and Blood Institute (NHLBI) 80
Large-scale testing (Phase 3)Ended earlyNCT01303679
What this trial is testing

1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

Who this might be right for
First Line Metastatic Breast Cancer
ARCAGY/ GINECO GROUP 117
Next Page